32 results
Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)
27 Oct 2023
Mirvat Alasnag provides her take on the AGENT IDE trial which was presented by Robert W. Yeh at TCT Congress 2023. This pivotal randomized trial compares the safety and efficacy of the AGENT DCB to conventional balloon angioplasty in patients with ISR. It is the first...
Author
The randomized PICSO-AMI-I trial: pressure-controlled intermittent coronary sinus occlusion in acute myocardial infarction
27 Oct 2023
Aaysha Cader interviews Giovanni Luigi De Maria about the results of the PICSO-AMI-I Trial which he presented during the TCT Congress 2023 in San Francisco.
Author
Author
TRISCEND II: Transcatheter tricuspid valve replacement in patients with severe TR
27 Oct 2023
Mirvat Alasnag interviews Susheel K. Kodali about the results of the TRISCEND II trial which he presented during the TCT Congress 2023 in San Francisco.
Data from the first 150 patients revealed that transcatheter valve replacement effectively improved tricuspid regurgitation and patient symptoms with low adverse events at...
Author
Author
TRILUMINATE: Quality of life after transcatheter tricuspid-valve repair vs. medical therapy in severe TR
27 Oct 2023
Luigi Biasco interviews Suzanne V. Arnold about the results of the randomized TRILUMINATE pivotal trial which she presented during the TCT Congress 2023 in San Francisco
Author
Author
Transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis and small aortic annuli: A randomized clinical trial (the VIVA Trial)
27 Oct 2023
Luis Ortega-Paz interviews Josep Rodés-Cabau on the results of the VIVA trial which he presented at TCT Congress 2023 in San Francisco.
Author
Author
CLASP IID one-year outcomes - Transcatheter edge-to-edge repair systems for degenerative MR
27 Oct 2023
Alessandro Sticchi interviews Robert L. Smith & Firas Zahr about the CLASP IID Trial and Registry which they presented during the TCT Congress 2023 in San Francisco.
The PASCAL system proved effective in treating high-risk patients with symptomatic degenerative mitral regurgitation, meeting primary and secondary endpoints while improving...
Author
Author
Author
T-PASS: Less than 1-month DAPT followed by ticagrelor monotherapy after DES Implantation for ACS
26 Oct 2023
Ali Nazmi Calik interviews Myeong-Ki Hong about the results of the T-Pass randomised trial which he presented during the #TCT Congress 2023 in San Francisco.
Author
Author
Four-Year Outcomes from the EVOLUT Low Risk Trial
26 Oct 2023
Dejan Milasinovic provides his take on the EVOLUT Low Risk trial, presented by Michael I. Reardon at TCT Congress 2023. 4-year results reveal a continuing trend towards lower combined rates of all-cause mortality and disabling stroke with TAVI compared with surgical aortic valve replacement (SAVR)
Author
Concomitant left atrial appendage occlusion and transcatheter aortic valve replacement among patients with atrial fibrillation – The WATCH-TAVR Trial
26 Oct 2023
Panos Xaplanteris provides his take on WATCH-TAVR results which were presented by Samir R. Kapadia at TCT Congress 2023.
Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - The WATCH TAVR Trial
Author
Five-year clinical and echocardiographic outcomes from the PARTNER 3 Low-Risk randomized trial
26 Oct 2023
Alex Sticchi provides his take on the 5-year outcomes from PARTNER 3 Low Risk which were presented by Martin B. Leon at TCT Congress 2023.
Author
